ATG7 and melanoma: It has also been demonstrated that treatment with dabrafenib more markedly inhibited growth and induced senescence in tumors derived from ATG7-deficient melanoma cells [71], further indicating that efficient autophagic flux limits the response of melanoma cells to anti-cancer drugs.